Dermatologic Cosmetic Laboratories - Active Mattifying Cleanser
Natural health product licensed in Canada
- Licence holder
- Dermatologic Cosmetic Laboratories
- NPN or DIN-HM
- 80077080
- Status
- Active licence
- Licence date
- 1 May 2017
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Topique
- Application type
- Traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 2-hydroxybenzoïque Source : Acide salicylique | 2 % |
Non-medicinal ingredients
Copolymère itaconate PEG-20 alkyl C10-C30 acrylates/aminoacrylates, Papaïne, Aqua, Extrait de racine de Panax ginseng, Poly(propylène glycol), Distéarate de glycol, Sorbate de potassium, D-Panthénole, Oléfine (en C14 à 16) sulfonate de sodium, Huile essentielle d'Ormenis multicaulis, Benzoate de sodium, Extrait de feuilles de Ginkgo biloba, EDTA de sodium, Oxyde de cocamidopropylamine, Extrait d'algue, Lauroyl sarcosinate de sodium, Citrate de sodium, Vitamine E, Cocamidopropyl bétaïne, Chlorophosphate de linoléamidopropyl PG-dimonium, Glycérine, Acide lactique, Chlorure de sodium, Sulfate de sodium, Phénoxyéthanol, Extrait de graine de Cola Acuminata, Extrait de fruit de Pyrus malus (pomme)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 millilitre ; maximum: 4 millilitre | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
For the treatment of acne.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For external use only. Using topical acne drugs may increase dryness or irritation of the skin. If this occurs, only one of them should be used unless directed by a doctor. When using this product avoid contact with eyes. If contact occurs immediately flush with water. Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away. If you develop hives, swelling of the eyes and mouth, blistering or difficulty breathing, get medical help right away.
- Effets indésirables connus
Discontinue use if excessive skin irritation develops or increases. If irritation persists or spreads beyond the site of application, consult a health care professional. For more severe cases, and/or if substantial improvement is not apparent within 6-8 weeks, consult a health care professional.
Source
Official Health Canada record, licence 80077080
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.